These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21469583)

  • 1. Quantifying fracture risk. Focus on postmenopausal women and older men.
    Wright WL
    Adv NPs PAs; 2011 Mar; 2(3):31-2, 34, 36-7. PubMed ID: 21469583
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recent fracture on health-related quality of life in postmenopausal women.
    Brenneman SK; Barrett-Connor E; Sajjan S; Markson LE; Siris ES
    J Bone Miner Res; 2006 Jun; 21(6):809-16. PubMed ID: 16753011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk in postmenopausal women.
    Landis DM
    Nurse Pract; 2005 Nov; 30(11):48, 53-8. PubMed ID: 16276300
    [No Abstract]   [Full Text] [Related]  

  • 6. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?
    Sanders KM; Nicholson GC; Watts JJ; Pasco JA; Henry MJ; Kotowicz MA; Seeman E
    Bone; 2006 May; 38(5):694-700. PubMed ID: 16507356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, etiology, and diagnosis of osteoporosis.
    Lane NE
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology and epidemiology of osteoporosis in men].
    Fujiwara S
    Clin Calcium; 2006 Mar; 16(3):444-8. PubMed ID: 16508126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in older men and women.
    Weigert JM
    Conn Med; 2003; 67(10):644-5. PubMed ID: 14677348
    [No Abstract]   [Full Text] [Related]  

  • 10. Fall risk: the clinical relevance of falls and how to integrate fall risk with fracture risk.
    Peeters G; van Schoor NM; Lips P
    Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):797-804. PubMed ID: 19945691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in osteoporosis. Men versus women.
    Orwoll ES; Bliziotes M
    Rheum Dis Clin North Am; 1994 Aug; 20(3):671-89. PubMed ID: 7984784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
    Martens MG
    J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of postmenopausal osteoporosis].
    Ribot C; Trémollières F; Pouillès JM
    Rev Prat; 2005 Feb; 55(4):393-400. PubMed ID: 15828618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refracture following fracture liaison service assessment illustrates the requirement for integrated falls and fracture services.
    Langridge CR; McQuillian C; Watson WS; Walker B; Mitchell L; Gallacher SJ
    Calcif Tissue Int; 2007 Aug; 81(2):85-91. PubMed ID: 17629737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
    McCarus DC
    Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.